Clinical Trials Browser

OTHER × Prostatic Neoplasms × tasquinimod × Clear all

NCT02159950 2023-04-27

Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 2 Completed

2 enrolled 7 charts

Prostatic Neoplasms

NCT01513733 2018-09-04

CATCH

Phase 1 Completed

Prostatic Neoplasms

NCT02396368 2015-11-20

Radium-223

Phase 1 Withdrawn

Prostatic Neoplasms